Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
14900 Interurban Avenue South, Suite 271, PMB 98, Seattle, WA, 98168, US
Namely, the investment helps fund further development, approval, and launch of Anagram’s ANG003.
By: Patrick Lavery
The veteran drug development leader brings extensive global experience.
By: Charlie Sternberg
New infrastructure aims to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval life cycle management.
Practical guidance for sponsors to extract meaningful insight—and avoid costly surprises— when vetting CDMO partners.
By: Michael Spangler, Tobi Williams
The Eterna Line ECUT 1060 Elite ER is the most recent addition to Colbert’s folding carton die-cutting equipment in its Kenosha facility.
Duvakitug is currently in phase 3 trials for ulcerative colitis and Crohn’s disease.
By: Kristin Brooks
Site provides process R&D, analytical and stability testing, cGMP API manufacturing, and CMC support.
Following a prior Refusal-to-File and Type A meeting, the FDA's CBER will proceed to review BLA for mRNA-1010.
The set of four models are designed to support biopharmaceutical companies across all key stages of protein CMC development.
Ji will drive strategic planning, operations, and the continued expansion of the company’s development and manufacturing capabilities.
Strategic financing will advance development of sac-TMT while Merck continues to progress its expansive pipeline.
By: Rachel Klemovitch
Aims to deliver practical standards that make life sciences data AI-ready and interoperable from the lab through to manufacturing.
Aims to advance the development of a weekly microneedle patch for the treatment of overactive bladder (OAB).
Together, the companies will integrate IND Drafting and CMC Support into Wheeler's ModularCMC Platform.
Certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
